Project cooperationUpdated on 4 February 2026
Next-generation bioresorbable Mg/Ti alloy implants for regenerative medicine
Professor at University of Lille
Villeneuve d'Ascq, France
About
We are a materials science research group at University of Lille specializing in next-generation bioresorbable metallic implants based on magnesium and titanium alloys. Our expertise spans:
• Alloy design and characterization (Mg-Zn-Ca, Mg-based BMG, beta-titanium systems)
• Mechanical testing (tensile, impact, Charpy) and phase diagram analysis
• Corrosion behavior assessment and electrochemical analysis
• In vitro biocompatibility testing and osteogenic cell response
• Advanced characterization techniques (SEM, TEM, TAP, PAS)
• Additive manufacturing and processing (3D printing, cold spray)
• Regulatory science and translational pathways for medical devices
We seek partners for collaborative research on:
- NAMs development for implant testing and corrosion/degradation models
- Regenerative medicine applications with cell/growth factor integration
- Follow-on funding leveraging EU-funded research (RAISE 2026 consortium)
- Regulatory science for bioresorbable implant standardization
- Patient-centered implant design optimization
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Consortium/Coordinator seeks Partners
Similar opportunities
Project cooperation
R&D services in bioprocess development and bioreactors for in vitro screening platforms
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Filip Donvil
Co-development Architect at Antleron
Leuven, Belgium
Project cooperation
Biomaterials and Additive Manufacturing
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Bartolomeo Coppola
Associate Professor at Politecnico di Torino
Torino, Italy
Project cooperation
Human Collagen and Xeno-free Human ECM for Medical Applications
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Fabian Trumper
CEO at Arrakis Bio
Modi'in, Israel